How this instrument works
Prothrombin time measures how many seconds it takes a plasma sample to clot after a reagent called thromboplastin is added. The trouble is that thromboplastin isn't one standard substance — different manufacturers' reagents respond to a drop in clotting factors with different sensitivity, so the same patient's blood can clot in 18 seconds on one instrument and 15 on another, with no change in how anticoagulated they actually are. The raw ratio of patient time to a control's normal time therefore isn't something you can compare across labs on its own.
The International Normalized Ratio fixes that by raising the raw ratio to a power: the International Sensitivity Index, or ISI, a number every batch of thromboplastin reagent is assigned against a World Health Organization reference standard. A reagent close to the WHO standard carries an ISI near 1.0 and barely changes the ratio; a less sensitive reagent carries a higher ISI and pulls the exponent up further. Once raised to that power, a warfarin patient's INR means roughly the same thing whether the sample was run in a rural clinic or a university hospital lab.
A healthy person not taking any blood thinner sits at an INR near 1.0, since their patient time and the control time are close to equal. Someone on warfarin therapy is deliberately pushed higher; a commonly cited therapeutic range for conditions like atrial fibrillation or a treated blood clot is 2.0 to 3.0, though the right target band shifts with the specific reason someone is anticoagulated — a mechanical heart valve, for instance, is often managed toward a higher range. There is no single universal target that applies to every patient on the drug.
- Enter Patient PT — the prothrombin time in seconds measured from the patient's blood sample.
- Enter Control PT — the mean normal prothrombin time in seconds for the reagent and instrument combination used by that lab.
- Enter ISI — the International Sensitivity Index printed on the reagent's package insert for that specific lot.
- Read the resulting INR; compare it against the therapeutic range your clinician has set for the specific reason anticoagulation is being managed.
Worked example — PT 24s, control 12s, ISI 1.2
A patient's prothrombin time comes back at 24 seconds, against a control PT of 12 seconds, using a reagent with an ISI of 1.2. The raw ratio is 24 / 12 = 2.0. Raised to the power of 1.2, that becomes 2.0^1.2 ≈ 2.297 — an INR of about 2.30, comfortably inside the 2.0-3.0 range commonly targeted for warfarin therapy in conditions like atrial fibrillation.
Compare that to a reagent with an ISI of exactly 1.0 instead of 1.2, same 24-second PT and 12-second control: 2.0^1.0 is simply 2.0. The two reagents describe the same blood draw with two different final numbers — 2.30 versus 2.00 — purely because of how sensitive each thromboplastin is. That gap is exactly the distortion the ISI exponent is designed to correct for once it's applied properly.
Questions
Why does the formula raise the PT ratio to a power instead of just using the ratio directly?
Because different labs use different thromboplastin reagents, and those reagents vary in how strongly they respond to reduced clotting factors. A raw ratio of patient time to control time would give a different number for the identical blood sample depending purely on which reagent ran the test. Raising that ratio to the power of the reagent's own International Sensitivity Index cancels out most of that reagent-to-reagent variation, so an INR of 2.5 means roughly the same degree of anticoagulation wherever it was measured.
What is a normal INR for someone not on blood thinners?
About 1.0. That reflects a patient PT essentially equal to the control PT, since there's no anticoagulant slowing the clotting cascade. Small day-to-day variation around 1.0 is normal and doesn't indicate a bleeding or clotting problem on its own.
What INR range should a warfarin patient be targeting?
It depends on why they're anticoagulated, so there's no single figure that fits everyone. A commonly cited range for atrial fibrillation or a treated deep vein clot is 2.0 to 3.0, while a mechanical heart valve is often managed toward a higher target. The correct range for any specific patient is a decision for the prescribing clinician, not something this calculator can determine from the INR alone.
Where does the ISI number actually come from?
Manufacturers calibrate every lot of thromboplastin reagent against a World Health Organization international reference preparation, testing plasma from both normal donors and patients already stabilized on an anticoagulant. The resulting slope of that comparison becomes the ISI printed on the reagent's package insert — a reagent that behaves almost identically to the WHO reference gets an ISI near 1.0.
Can I use this calculator with a raw prothrombin time instead of an INR reading?
Yes — that's the point of it. Point-of-care coagulometers often display INR directly, but a standard lab report may give you patient PT, control PT, and the reagent's ISI separately, leaving you to combine them. Enter all three here exactly as the lab reports them and the calculator performs the exponentiation for you.
References
- International Normalized Ratio: Assessment, Monitoring, and Clinical Implications — StatPearls (NCBI Bookshelf)
- MedlinePlus — Prothrombin Time Test and INR (PT/INR)
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.